Compare IDEXX Laboratories, Inc. (IDXX) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Motorola Solutions Inc — how do they compare? IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B), while Motorola Solutions Inc trades at $470.61 (market cap $77.26B). The key difference: Motorola Solutions Inc is the larger of the two by market cap, and Motorola Solutions Inc pays a 1.04% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | MSI | |
|---|---|---|
Market Cap | $46.22B | $77.26B |
Sector | Health | Technology |
52-Week High | $766.68 | $490.30 |
52-Week Low | $526.44 | $363.83 |
Enterprise Value | $47.12B | $86.17B |
Dividend Yield | — | 1.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Motorola Solutions (MSI) trades at $468.70, up 1.45% on the day, reflecting strong momentum after Q2 2026 earnings beat estimates. The stock shows bullish technical signals with a golden cross pattern and is near its pivot point of $467. Fundamentally, revenue grew 13% year-over-year in Q2, with record backlog of $15.6 billion driving raised full-year guidance. Valuation ratios remain elevated with a P/E of 36.79, while profitability is robust with a net margin of 17.44% and ROE of 91.98%.
Outlook is positive given strong demand in public safety segments and upward earnings revisions, but risks include high valuation sensitivity and execution challenges. The consensus price target of $533.80 implies ~14% upside, supported by 71% analyst buy ratings. Investors should weigh growth prospects against premium multiples and monitor cash flow trends amid significant investing outflows.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
